Impact of diagnostic delays and short treatment regimens on outcomes of rifampicin-resistant tuberculosis patients in Cameroon
Improving treatment outcomes for patients with chronic inflammatory diseases through identification of predictive biomarkers and therapeutic drug monitoring of new biologicals
Evaluation of intermittent preventive treatment during pregnancy (IPTp) in Chókwè district, Southern Mozambique: coverage and effect on pregnancy and parasitological outcomes
The immunomodulatory role of prednisone in TB-HIV co-infected patients and assessment of its impact on clinical and TB treatment outcomes
Identification of risk factors and prediction of adverse treatment outcomes in visceral leishmaniasis in Ethiopia
Treatment and outcomes for patients with depression who are partial responders to SSRI treatment: post-hoc analysis findings from the FINDER European observational study
Treatment of supraglottic squamous cell carcinoma with advanced technologies: observational prospective evaluation of oncological outcomes, functional outcomes, quality of life and cost-effectiveness (SUPRA-QoL)
Treatment outcomes of interdisciplinary care on speech and health-related quality of life outcomes in adults with cleft palate
Effect of reliance on Xpert MTB/RIF on time to treatment and multidrug-resistant tuberculosis treatment outcomes in Tanzania: a retrospective cohort study
Effect of primary tumor location on second-or later-line treatment outcomes in patients with RAS wild-type metastatic colorectal cancer and all treatment lines in patients with RAS mutations in four randomized panitumumab studies
SPIDER-FLOW: State-of-the-art high-Parameter Immunology and DEvelopmental biology Research FLOW cytometer (SPIDER-FLOW)
Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy : a randomized proof-of-concept clinical trial